Cell and Gene Manufacturing and Logistics
-
Fine-Tuning Bioseparation Column Geometry With 3D-Printed Monoliths
11/3/2026
If geometric control, not retention, is the priority in viral vector separation, research group says high-resolution 3D-printing chromatography monoliths can be useful.
-
The Importance Of Starting Material In Breakthrough Cancer Treatments
11/2/2026
Autologous TIL therapy starts with patient biology no developer can standardize. Discover which parts of the process can be controlled, and how far that goes toward reproducible products.
-
TheraPEAK® ActiCell® T Cell Activation Reagent
11/2/2026
Bead-free activation of human T cells through biodegradable nanoparticles aims to protect cell health during expansion, with the reagent cleared by simple washing or centrifugation.
-
Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
11/2/2026
Mayo Clinic experts shared where, when, and how automation can make the biggest impact on autologous CAR T manufacturing.
-
The Body As A Bioreactor – The Execution
10/31/2026
Genomic medicine depends as much on infrastructure as on the therapies themselves. Distributed production, scalable processes, and evolving regulation shape whether these medicines reach patients.
-
Project Managers: The Game Changers And Architects Of CDMO Partnerships
10/31/2026
Strong project leadership, technical expertise, and clear communication are key to outsourcing success. Learn how strategic oversight accelerates development and ensures reliable results.
-
Closing The CAR-T Access Gap With Hospital-Based Manufacturing
10/30/2026
Improvements in closed-loop processing and lower material costs could bring distributed manufacturing within reach. Hospitals still need to stand up production suites.
-
How To Stand Up A Hospital-Based CAR-T Manufacturing Network
10/30/2026
Estimates show that a small hospital-based, modular GMP facility can deliver more than 250 products per year with more flexibility than fully automated, integrated equipment.
-
What Is Cell And Gene Therapy?
10/29/2026
Cell and gene therapy corrects disease at its genetic source, using engineered cells or delivered genes to pursue lasting cures where conventional treatment has failed or does not exist.
-
A View On Exosomes
10/29/2026
Nano-scale delivery vehicles produced by the body's own cells are opening new routes in treatment and liquid biopsy diagnostics, with manufacturing still an open challenge.